Funds and ETFs MediPharm Labs Corp.

Equities

LABS

CA58504D1006

Pharmaceuticals

Market Closed - Toronto S.E. 01:56:02 2024-04-26 pm EDT 5-day change 1st Jan Change
0.08 CAD 0.00% Intraday chart for MediPharm Labs Corp. 0.00% +23.08%

ETFs positioned on MediPharm Labs Corp.

Name Weight AuM 1st Jan change Investor Rating
0.83% 35 M€ +18.97% -
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. The Company's subsidiary, Harvest Medicine provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
0.08 CAD
Average target price
0.1 CAD
Spread / Average Target
+25.00%
Consensus
  1. Stock Market
  2. Equities
  3. LABS Stock
  4. Funds and ETFs MediPharm Labs Corp.